Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
10.43
-0.28 (-2.61%)
Feb 21, 2025, 4:00 PM EST - Market closed
Evolent Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 2,555 | 1,964 | 1,352 | 907.96 | 924.64 | Upgrade
|
| Revenue Growth (YoY) | 30.09% | 45.26% | 48.91% | -1.80% | 34.57% | Upgrade
|
| Cost of Revenue | 2,187 | 1,503 | 1,035 | 657.55 | 696.58 | Upgrade
|
| Gross Profit | 367.35 | 460.47 | 316.58 | 250.41 | 228.06 | Upgrade
|
| Selling, General & Admin | 246.64 | 306.27 | 244.37 | 207.78 | 198.04 | Upgrade
|
| Operating Expenses | 365.01 | 429.69 | 311.56 | 267.82 | 258.87 | Upgrade
|
| Operating Income | 2.34 | 30.78 | 5.02 | -17.41 | -30.81 | Upgrade
|
| Interest Expense | -24.72 | -54.21 | -15.57 | -25.43 | -28.33 | Upgrade
|
| Interest & Investment Income | 5.54 | 5.26 | 1.37 | 0.41 | 2.63 | Upgrade
|
| Earnings From Equity Investments | -3.44 | 1.29 | 4.57 | 13.18 | 10.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.07 | -62.53 | -45.89 | -0.15 | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | -20.21 | -79.4 | -50.51 | -29.4 | -46.58 | Upgrade
|
| Merger & Restructuring Charges | -13.53 | -51.84 | -24.9 | -11.72 | -3.39 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -215.1 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -47.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -8.11 | - | 45.94 | -0.7 | Upgrade
|
| Asset Writedown | -2.59 | -24.07 | - | - | - | Upgrade
|
| Other Unusual Items | -26.71 | -38.99 | 13.33 | -34.62 | -17.64 | Upgrade
|
| Pretax Income | -63.04 | -202.41 | -62.08 | -29.8 | -330.54 | Upgrade
|
| Income Tax Expense | -1.41 | -89.37 | -43.38 | 0.48 | -2.37 | Upgrade
|
| Earnings From Continuing Operations | -61.62 | -113.04 | -18.7 | -30.28 | -328.17 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.46 | -7.32 | -6.07 | Upgrade
|
| Net Income to Company | -61.62 | -113.04 | -19.16 | -37.6 | -334.25 | Upgrade
|
| Net Income | -61.62 | -113.04 | -19.16 | -37.6 | -334.25 | Upgrade
|
| Preferred Dividends & Other Adjustments | 31.83 | 29.22 | - | - | - | Upgrade
|
| Net Income to Common | -93.45 | -142.26 | -19.16 | -37.6 | -334.25 | Upgrade
|
| Shares Outstanding (Basic) | 115 | 111 | 94 | 86 | 85 | Upgrade
|
| Shares Outstanding (Diluted) | 115 | 111 | 94 | 86 | 85 | Upgrade
|
| Shares Change (YoY) | 3.08% | 18.73% | 8.87% | 1.34% | 3.11% | Upgrade
|
| EPS (Basic) | -0.81 | -1.28 | -0.20 | -0.44 | -3.94 | Upgrade
|
| EPS (Diluted) | -0.81 | -1.28 | -0.20 | -0.44 | -3.94 | Upgrade
|
| Free Cash Flow | -36.85 | 113.84 | -59.08 | 11.25 | -48.29 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | 1.02 | -0.63 | 0.13 | -0.57 | Upgrade
|
| Gross Margin | 14.38% | 23.45% | 23.42% | 27.58% | 24.66% | Upgrade
|
| Operating Margin | 0.09% | 1.57% | 0.37% | -1.92% | -3.33% | Upgrade
|
| Profit Margin | -3.66% | -7.24% | -1.42% | -4.14% | -36.15% | Upgrade
|
| Free Cash Flow Margin | -1.44% | 5.80% | -4.37% | 1.24% | -5.22% | Upgrade
|
| EBITDA | 120.71 | 127.5 | 45.22 | 16.13 | 5.76 | Upgrade
|
| EBITDA Margin | 4.72% | 6.49% | 3.34% | 1.78% | 0.62% | Upgrade
|
| D&A For EBITDA | 118.37 | 96.72 | 40.2 | 33.54 | 36.58 | Upgrade
|
| EBIT | 2.34 | 30.78 | 5.02 | -17.41 | -30.81 | Upgrade
|
| EBIT Margin | 0.09% | 1.57% | 0.37% | -1.92% | -3.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.